Ceapro Quote - CZO

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.225

Bid

0.16

Ask

0.30

Volume

0.00 Day's Range 0.00

0.15 52 Week Range 0.295

Market Cap

17.616M

Previous Close

0.225

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

78,293,000

Dividend Yield

PE Ratio

-3.65

Earnings Per Share (EPS)

-0.06

Revenue

9.63M

Net Profit

-4.71M

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Headquarters

Edmonton, Alberta, Can

Founded

Ceapro Inc is listed in the Medicinal Chems,botanicl Pds sector of the TSX Venture Exchange with ticker CZO. The last closing price for Ceapro was $0.23. Over the last year, Ceapro shares have traded in a share price range of $ 0.15 to $ 0.295.

Ceapro currently has 78,293,000 shares outstanding. The market capitalization of Ceapro is $17.62 million. Ceapro has a price to earnings ratio (PE ratio) of -3.65.

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF...

Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZO

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZO Canada NewsWire VANCOUVER, BC, le 3 juin 2024 VANCOUVER, BC, le 3 juin 2024 /CNW/...

Canadian Investment Regulatory Organization Trading Halt - CZO

Canadian Investment Regulatory Organization Trading Halt - CZO Canada NewsWire VANCOUVER, BC, June 3, 2024 VANCOUVER, BC, June 3, 2024 /CNW/ - The following issues have been halted by...

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

– Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pilot scale...

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

– 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the...

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased...

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.225	0.225	0.225	0	0	CS
4	0	0	0.225	0.225	0.225	0	0	CS
12	0	0	0.225	0.225	0.225	0	0	CS
26	-0.045	-16.6666666667	0.27	0.27	0.225	1448	0.26141436	CS
52	-0.035	-13.4615384615	0.26	0.295	0.15	21426	0.23362096	CS
156	-0.355	-61.2068965517	0.58	0.82	0.15	29244	0.46918794	CS
260	-0.1	-30.7692307692	0.325	0.98	0.14	36879	0.50904729	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ENTGEntourage Health Corp	$ 0.015 (200.00%)	2.18M
ACAP.PAtlas One Capital Corporation	$ 0.015 (200.00%)	221.8k
SSESilver Spruce Resources Inc	$ 0.01 (100.00%)	18.01k
XCAP.PExelerate Capital Corp	$ 0.05 (66.67%)	129k
POOLPool Safe Inc	$ 0.04 (60.00%)	158.3k
WWTWater Ways Technologies Inc	$ 0.005 (-50.00%)	52.11k
OSIXOceansix Future Paths Ltd	$ 0.005 (-50.00%)	2.12M
JHCJinhua Capital Corporation	$ 0.005 (-50.00%)	140k
DMDataMetrex AI Limited	$ 0.005 (-50.00%)	130k
MDK.PMDK Acquisition Inc	$ 0.05 (-50.00%)	5k
EGTEguana Technologies Inc	$ 0.01 (0.00%)	2.55M
ENTGEntourage Health Corp	$ 0.015 (200.00%)	2.18M
OSIXOceansix Future Paths Ltd	$ 0.005 (-50.00%)	2.12M
RIORio2 Limited New	$ 0.63 (-4.55%)	2.11M
GBUGabriel Resources Ltd	$ 0.015 (0.00%)	2.02M

stocker11 8 years ago

Have they started testing the product for Cholesterol reduction.

👍️0

stocker11 8 years ago

Looking to buy in soon - should I wait until for the K is filed at the end of the month?

👍️0

Michon 8 years ago

What make's this stock special?

👍️0

notofthisworld 8 years ago

This article underlines the potential of this company.

http://www.theglobeandmail.com/globe-investor/investment-ideas/why-this-canadian-biotech-firms-cheap-stock-is-a-hidden-gem/article33325243/

👍️0

notofthisworld 8 years ago

This won't be under 2$ for much longer.

👍️0

	Real-time Prices	Level 2
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

BLACK FRIDAY

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Ceapro Inc (CZO) Share Price

Ceapro Inc (CZO)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Ceapro Inc

Ask ADVFN Intelligence (AI)

CZO Latest News

Movers

CZO Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%